The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

The team found a notable correlation between genetics that predicted low cholesterol and a lower risk of dementia, suggesting ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

Share on PinterestLower your cholesterol to lower your dementia risk, a new study confirms. Image credit: Anna ...

Scientists do not fully understand what causes the chronic neurodegenerative disease Alzheimer's, but they are examining a ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

Spirit of the Coast Analytics said Anavex’s Alzheimer’s drug Blarcamesine is likely to gain conditional marketing ...

This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...

Alector said on Tuesday its experimental drug failed to slow the progression of a rare form of dementia in a late-stage trial, prompting the company to end the study and cut nearly half its workforce.

Alector Inc. cuts its workforce by nearly 50% following the failure of its dementia drug trial, signalling challenges in the ...